Observing the natural history of coronary artery disease using FFR measurements

A Multicenter, Prospective Cohort to Evaluate the Natural History of FFR Guided Percutaneous Coronary Intervention

Observational CardioVascular Research Foundation, Korea · NCT01366404

This study is tracking around 20,000 patients with coronary artery disease to see how their condition changes over two years using special heart measurements.

Quick facts

Study typeObservational
Enrollment20000 (estimated)
Ages35 Years and up
SexAll
SponsorCardioVascular Research Foundation, Korea Academic / other
Locations29 sites (Anyang and 28 other locations)
Trial IDNCT01366404 on ClinicalTrials.gov

What this trial studies

This observational study aims to enroll approximately 20,000 patients with Fractional Flow Reserve (FFR) measurements to evaluate the natural history of coronary lesions over a two-year period. The study will be conducted at multiple centers across Korea, focusing on clinical and imaging follow-up of participants. By tracking these patients, researchers hope to gain insights into the progression of coronary artery disease and the implications of FFR-guided interventions.

Who should consider this trial

Good fit: Ideal candidates are individuals aged 35 years and older with FFR measurements indicating coronary artery stenosis.

Not a fit: Patients with severe coronary artery conditions, such as TIMI flow less than 3 or those with a life expectancy of less than two years, may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could enhance understanding of coronary artery disease progression and improve patient management strategies.

How similar studies have performed: While this approach is observational, similar studies using FFR have shown promise in understanding coronary artery disease, indicating potential for valuable insights.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 35 years and older
* FFR measurement on one and more coronary artery stenosis
* Willing and able to provide informed, written consent

Exclusion Criteria:

* Stenosis with TIMI\<3 flow
* Graft vessel
* Ejection fraction \< 30%
* Angiographic evidence of extreme tortuosity or calcified coronary vessels
* Suspected coronary spasm even after sufficient nitrate injected
* Life expectancy \<2 year
* Planned cardiac surgery or planned major non cardiac surgery
* Woman who are breastfeeding, pregnant or planning to become pregnant during the course of the study

Imaging study specific exclusion criteria

* visually-estimated angiographic reference segment diameter of \<2.75mm or \>4.0mm
* Inappropriate for IVUS/VH/OCT procedures : inability for imaging wire or catheter to pass through the tight stenosis, severe calcification, angulation

Where this trial is running

Anyang and 28 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Coronary Artery DiseaseFFR
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.